FDA recall D-0357-2026
Teva Pharmaceuticals USA, Inc · Class II · drug
Product
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Reason for recall
Failed Dissolution Specifications
Distribution
Nationwide
Key facts
- Status
- Ongoing
- Initiation date
- 2026-01-29
- Report date
- 2026-03-11
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Parsippany, NJ, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0357-2026